CID 772165

N-[4-(1h-1,3-benzimidazol-2-yl)phenyl]-2-morpholinoacetamide

Structural Information

Molecular Formula
C19H20N4O2
SMILES
C1COCCN1CC(=O)NC2=CC=C(C=C2)C3=NC4=CC=CC=C4N3
InChI
InChI=1S/C19H20N4O2/c24-18(13-23-9-11-25-12-10-23)20-15-7-5-14(6-8-15)19-21-16-3-1-2-4-17(16)22-19/h1-8H,9-13H2,(H,20,24)(H,21,22)
InChIKey
KKTHHIRXFOJWCS-UHFFFAOYSA-N
Compound name
N-[4-(1H-benzimidazol-2-yl)phenyl]-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

6
References

0
Patents

336.15863 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 337.16591 177.4
[M+Na]+ 359.14785 182.8
[M-H]- 335.15135 182.9
[M+NH4]+ 354.19245 186.4
[M+K]+ 375.12179 177.5
[M+H-H2O]+ 319.15589 166.4
[M+HCOO]- 381.15683 193.2
[M+CH3COO]- 395.17248 186.1
[M+Na-2H]- 357.13330 181.4
[M]+ 336.15808 174.1
[M]- 336.15918 174.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.